SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Veru Inc. – ‘10-Q’ for 6/30/21 – ‘XML’

On:  Thursday, 8/12/21, at 12:20pm ET   ·   For:  6/30/21   ·   Accession #:  863894-21-9   ·   File #:  1-13602

Previous ‘10-Q’:  ‘10-Q’ on 5/12/21 for 3/31/21   ·   Next:  ‘10-Q’ on 2/9/22 for 12/31/21   ·   Latest:  ‘10-Q’ on 5/8/24 for 3/31/24   ·   10 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/12/21  Veru Inc.                         10-Q        6/30/21   82:12M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.09M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
11: R1          Document and Entity Information                     HTML     76K 
12: R2          Condensed Consolidated Balance Sheets               HTML    125K 
13: R3          Condensed Consolidated Balance Sheets               HTML     37K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     96K 
15: R5          Condensed Consolidated Statements of Stockolders'   HTML     91K 
                Equity                                                           
16: R6          Condensed Consolidated Statements of Cash Flows     HTML    124K 
17: R7          Basis of Presentation                               HTML     38K 
18: R8          Sale of PREBOOST Business                           HTML     29K 
19: R9          Fair Value Measurements                             HTML     83K 
20: R10         Revenue from Contracts with Customers               HTML    137K 
21: R11         Accounts Receivable and Concentration of Credit     HTML     63K 
                Risk                                                             
22: R12         Balance Sheet Information                           HTML    113K 
23: R13         Intangible Assets and Goodwill                      HTML    108K 
24: R14         Debt                                                HTML    181K 
25: R15         Stockholders' Equity                                HTML     49K 
26: R16         Share-based Compensation                            HTML    211K 
27: R17         Leases                                              HTML    122K 
28: R18         Contingent Liabilities                              HTML     29K 
29: R19         Income Taxes                                        HTML    256K 
30: R20         Paycheck Protection Program                         HTML     26K 
31: R21         Net (Loss) Income) Per Share                        HTML    121K 
32: R22         Industry Segments                                   HTML     83K 
33: R23         Basis of Presentation (Policy)                      HTML     43K 
34: R24         Fair Value Measurements (Tables)                    HTML     75K 
35: R25         Revenue from Contracts with Customers (Tables)      HTML    129K 
36: R26         Accounts Receivable and Concentration of Credit     HTML     49K 
                Risk (Tables)                                                    
37: R27         Balance Sheet Information (Tables)                  HTML    112K 
38: R28         Intangible Assets and Goodwill (Tables)             HTML    101K 
39: R29         Debt (Tables)                                       HTML    150K 
40: R30         Share-based Compensation (Tables)                   HTML    193K 
41: R31         Leases (Tables)                                     HTML    114K 
42: R32         Income Taxes (Tables)                               HTML    246K 
43: R33         Net (Loss) Income Per Share (Tables)                HTML    117K 
44: R34         Industry Segments (Tables)                          HTML     74K 
45: R35         Sale of PREBOOST Business (Narrative) (Details)     HTML     48K 
46: R36         Fair Value Measurements (Reconciliation of the      HTML     26K 
                Beginning and Ending Liability Balance) (Details)                
47: R37         Fair Value Measurements (Schedule of Qualitative    HTML     37K 
                Information) (Details)                                           
48: R38         Revenue from Contracts with Customers (Narrative)   HTML     24K 
                (Details)                                                        
49: R39         Revenue from Contracts with Customers (Revenue      HTML     37K 
                from Customers by Products) (Details)                            
50: R40         Revenue from Contracts with Customers (Revenue by   HTML     41K 
                Geographic Area) (Details)                                       
51: R41         Accounts Receivable and Concentration of Credit     HTML     52K 
                Risk (Narrative) (Details)                                       
52: R42         Accounts Receivable and Concentration of Credit     HTML     30K 
                Risk (Components of Accounts Receivable) (Details)               
53: R43         Balance Sheet Information (Components Of            HTML     39K 
                Inventory) (Details)                                             
54: R44         Balance Sheet Information (Summary of Plant and     HTML     47K 
                Equipment) (Details)                                             
55: R45         Intangible Assets and Goodwill (Narrative)          HTML     35K 
                (Details)                                                        
56: R46         Intangible Assets and Goodwill (Gross Carrying      HTML     44K 
                Amounts and Net Book Value of Intangible Assets)                 
                (Details)                                                        
57: R47         Debt (Narrative) (Details)                          HTML     96K 
58: R48         Debt (Credit Agreement) (Details)                   HTML     38K 
59: R49         Debt (Residual Royalty Agreement Liability)         HTML     40K 
                (Details)                                                        
60: R50         Debt (Credit Agreement Interest Expense) (Details)  HTML     32K 
61: R51         Stockholders' Equity (Narrative) (Details)          HTML    101K 
62: R52         Share-based Compensation (Narrative) (Details)      HTML     85K 
63: R53         Share-based Compensation (Recorded Share-Based      HTML     32K 
                Compensation Expenses) (Details)                                 
64: R54         Share-based Compensation (Weighted Average          HTML     35K 
                Assumptions for Options Granted) (Details)                       
65: R55         Share-based Compensation (Summary of Stock Options  HTML     57K 
                Outstanding and Exercisable) (Details)                           
66: R56         Leases (Narrative) (Details)                        HTML     41K 
67: R57         Leases (Components of Lease Cost) (Details)         HTML     38K 
68: R58         Leases (Summary of Lease Information) (Details)     HTML     31K 
69: R59         Contingent Liabilities (Narrative) (Details)        HTML     23K 
70: R60         Income Taxes (Narrative) (Details)                  HTML     71K 
71: R61         Income Taxes (Reconciliation of Income Tax Expense  HTML     51K 
                (Benefit)) (Details)                                             
72: R62         Income Taxes (Significant Components of Deferred    HTML     70K 
                Tax Assets and Liabilities) (Details)                            
73: R63         Income Taxes (Schedule of Deferred Tax Amounts      HTML     32K 
                Classified in Balance Sheets) (Details)                          
74: R64         Paycheck Protection Program (Narrative) (Details)   HTML     27K 
75: R65         Net (Loss) Income Per Share (Narrative) (Details)   HTML     23K 
76: R66         Net (Loss) Income Per Share (Schedule Of Earnings   HTML     63K 
                Per Share, Basic And Diluted) (Details)                          
77: R67         Industry Segments (Narrative) (Details)             HTML     23K 
78: R68         Industry Segments (Schedule of Segment Reporting    HTML     34K 
                Information) (Details)                                           
80: XML         IDEA XML File -- Filing Summary                      XML    153K 
10: XML         XBRL Instance -- veru-20210630x10q_htm               XML   3.63M 
79: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K 
 6: EX-101.CAL  XBRL Calculations -- veru-20210630_cal               XML    206K 
 7: EX-101.DEF  XBRL Definitions -- veru-20210630_def                XML    595K 
 8: EX-101.LAB  XBRL Labels -- veru-20210630_lab                     XML   1.25M 
 9: EX-101.PRE  XBRL Presentations -- veru-20210630_pre              XML    995K 
 5: EX-101.SCH  XBRL Schema -- veru-20210630                         XSD    198K 
81: JSON        XBRL Instance as JSON Data -- MetaLinks              382±   551K 
82: ZIP         XBRL Zipped Folder -- 0000863894-21-000009-xbrl      Zip    239K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.21.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 273 </ContextCount>
<ElementCount> 426 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 78 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 10 </UnitCount>
<MyReports>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00090 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementCondensedConsolidatedBalanceSheets </Role>
<ShortName> CONDENSED CONSOLIDATED BALANCE SHEETS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementCondensedConsolidatedStatementsOfOperations </Role>
<ShortName> CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKOLDERS' EQUITY </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementCondensedConsolidatedStatementsOfStockoldersEquity </Role>
<ShortName> CONDENSED CONSOLIDATED STATEMENTS OF STOCKOLDERS' EQUITY </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows </Role>
<ShortName> CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 10101 - Disclosure - Basis of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureBasisOfPresentation </Role>
<ShortName> Basis of Presentation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 10201 - Disclosure - Sale of PREBOOST Business </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureSaleOfPreboostBusiness </Role>
<ShortName> Sale of PREBOOST Business </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 10301 - Disclosure - Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurements </Role>
<ShortName> Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 10401 - Disclosure - Revenue from Contracts with Customers </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomers </Role>
<ShortName> Revenue from Contracts with Customers </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 10501 - Disclosure - Accounts Receivable and Concentration of Credit Risk </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRisk </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 10601 - Disclosure - Balance Sheet Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureBalanceSheetInformation </Role>
<ShortName> Balance Sheet Information </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 10701 - Disclosure - Intangible Assets and Goodwill </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwill </Role>
<ShortName> Intangible Assets and Goodwill </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 10801 - Disclosure - Debt </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebt </Role>
<ShortName> Debt </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 10901 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureStockholdersEquity </Role>
<ShortName> Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 11001 - Disclosure - Share-based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensation </Role>
<ShortName> Share-based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 11101 - Disclosure - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeases </Role>
<ShortName> Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 11201 - Disclosure - Contingent Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureContingentLiabilities </Role>
<ShortName> Contingent Liabilities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 11301 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 11401 - Disclosure - Paycheck Protection Program </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosurePaycheckProtectionProgram </Role>
<ShortName> Paycheck Protection Program </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 11501 - Disclosure - Net (Loss) Income) Per Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureNetLossIncomePerShare </Role>
<ShortName> Net (Loss) Income) Per Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 11601 - Disclosure - Industry Segments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIndustrySegments </Role>
<ShortName> Industry Segments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 20102 - Disclosure - Basis of Presentation (Policy) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureBasisOfPresentationPolicy </Role>
<ShortName> Basis of Presentation (Policy) </ShortName>
<MenuCategory> Policies </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 30303 - Disclosure - Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurementsTables </Role>
<ShortName> Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureFairValueMeasurements </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 30403 - Disclosure - Revenue from Contracts with Customers (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersTables </Role>
<ShortName> Revenue from Contracts with Customers (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomers </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 30503 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRisk </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 30603 - Disclosure - Balance Sheet Information (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureBalanceSheetInformationTables </Role>
<ShortName> Balance Sheet Information (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureBalanceSheetInformation </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 30703 - Disclosure - Intangible Assets and Goodwill (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables </Role>
<ShortName> Intangible Assets and Goodwill (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwill </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 30803 - Disclosure - Debt (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtTables </Role>
<ShortName> Debt (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebt </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 31003 - Disclosure - Share-based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationTables </Role>
<ShortName> Share-based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensation </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 31103 - Disclosure - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesTables </Role>
<ShortName> Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeases </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 31303 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxes </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 31503 - Disclosure - Net (Loss) Income Per Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureNetLossIncomePerShareTables </Role>
<ShortName> Net (Loss) Income Per Share (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureNetLossIncomePerShare </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 31603 - Disclosure - Industry Segments (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIndustrySegmentsTables </Role>
<ShortName> Industry Segments (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIndustrySegments </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 40201 - Disclosure - Sale of PREBOOST Business (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureSaleOfPreboostBusinessNarrativeDetails </Role>
<ShortName> Sale of PREBOOST Business (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureSaleOfPreboostBusiness </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 40302 - Disclosure - Fair Value Measurements (Reconciliation of the Beginning and Ending Liability Balance) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurementsReconciliationOfBeginningAndEndingLiabilityBalanceDetails </Role>
<ShortName> Fair Value Measurements (Reconciliation of the Beginning and Ending Liability Balance) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureFairValueMeasurementsTables </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 40303 - Disclosure - Fair Value Measurements (Schedule of Qualitative Information) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureFairValueMeasurementsScheduleOfQualitativeInformationDetails </Role>
<ShortName> Fair Value Measurements (Schedule of Qualitative Information) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureFairValueMeasurementsTables </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 40401 - Disclosure - Revenue from Contracts with Customers (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersNarrativeDetails </Role>
<ShortName> Revenue from Contracts with Customers (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersTables </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 40402 - Disclosure - Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersRevenueFromCustomersByProductsDetails </Role>
<ShortName> Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersTables </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 40403 - Disclosure - Revenue from Contracts with Customers (Revenue by Geographic Area) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersRevenueByGeographicAreaDetails </Role>
<ShortName> Revenue from Contracts with Customers (Revenue by Geographic Area) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureRevenueFromContractsWithCustomersTables </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 40501 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskNarrativeDetails </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 40502 - Disclosure - Accounts Receivable and Concentration of Credit Risk (Components of Accounts Receivable) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskComponentsOfAccountsReceivableDetails </Role>
<ShortName> Accounts Receivable and Concentration of Credit Risk (Components of Accounts Receivable) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureAccountsReceivableAndConcentrationOfCreditRiskTables </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 40601 - Disclosure - Balance Sheet Information (Components Of Inventory) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureBalanceSheetInformationComponentsOfInventoryDetails </Role>
<ShortName> Balance Sheet Information (Components Of Inventory) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureBalanceSheetInformationTables </ParentRole>
<Position> 43 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 40602 - Disclosure - Balance Sheet Information (Summary of Plant and Equipment) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureBalanceSheetInformationSummaryOfPlantAndEquipmentDetails </Role>
<ShortName> Balance Sheet Information (Summary of Plant and Equipment) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureBalanceSheetInformationTables </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 40701 - Disclosure - Intangible Assets and Goodwill (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillNarrativeDetails </Role>
<ShortName> Intangible Assets and Goodwill (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables </ParentRole>
<Position> 45 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 40704 - Disclosure - Intangible Assets and Goodwill (Gross Carrying Amounts and Net Book Value of Intangible Assets) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillGrossCarryingAmountsAndNetBookValueOfIntangibleAssetsDetails </Role>
<ShortName> Intangible Assets and Goodwill (Gross Carrying Amounts and Net Book Value of Intangible Assets) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIntangibleAssetsAndGoodwillTables </ParentRole>
<Position> 46 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 40801 - Disclosure - Debt (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtNarrativeDetails </Role>
<ShortName> Debt (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebtTables </ParentRole>
<Position> 47 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 40802 - Disclosure - Debt (Credit Agreement) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtCreditAgreementDetails </Role>
<ShortName> Debt (Credit Agreement) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebtTables </ParentRole>
<Position> 48 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 40803 - Disclosure - Debt (Residual Royalty Agreement Liability) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtResidualRoyaltyAgreementLiabilityDetails </Role>
<ShortName> Debt (Residual Royalty Agreement Liability) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebtTables </ParentRole>
<Position> 49 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 40804 - Disclosure - Debt (Credit Agreement Interest Expense) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureDebtCreditAgreementInterestExpenseDetails </Role>
<ShortName> Debt (Credit Agreement Interest Expense) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureDebtTables </ParentRole>
<Position> 50 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 40901 - Disclosure - Stockholders' Equity (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureStockholdersEquityNarrativeDetails </Role>
<ShortName> Stockholders' Equity (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureStockholdersEquity </ParentRole>
<Position> 51 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 41001 - Disclosure - Share-based Compensation (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationNarrativeDetails </Role>
<ShortName> Share-based Compensation (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 52 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 41002 - Disclosure - Share-based Compensation (Recorded Share-Based Compensation Expenses) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationRecordedShareBasedCompensationExpensesDetails </Role>
<ShortName> Share-based Compensation (Recorded Share-Based Compensation Expenses) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 53 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 41003 - Disclosure - Share-based Compensation (Weighted Average Assumptions for Options Granted) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsForOptionsGrantedDetails </Role>
<ShortName> Share-based Compensation (Weighted Average Assumptions for Options Granted) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 54 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 41004 - Disclosure - Share-based Compensation (Summary of Stock Options Outstanding and Exercisable) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureShareBasedCompensationSummaryOfStockOptionsOutstandingAndExercisableDetails </Role>
<ShortName> Share-based Compensation (Summary of Stock Options Outstanding and Exercisable) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 55 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 41101 - Disclosure - Leases (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesNarrativeDetails </Role>
<ShortName> Leases (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 56 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 41102 - Disclosure - Leases (Components of Lease Cost) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesComponentsOfLeaseCostDetails </Role>
<ShortName> Leases (Components of Lease Cost) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 57 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 41103 - Disclosure - Leases (Summary of Lease Information) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureLeasesSummaryOfLeaseInformationDetails </Role>
<ShortName> Leases (Summary of Lease Information) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 58 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 41201 - Disclosure - Contingent Liabilities (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureContingentLiabilitiesNarrativeDetails </Role>
<ShortName> Contingent Liabilities (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureContingentLiabilities </ParentRole>
<Position> 59 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 41301 - Disclosure - Income Taxes (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesNarrativeDetails </Role>
<ShortName> Income Taxes (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 60 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 41303 - Disclosure - Income Taxes (Reconciliation of Income Tax Expense (Benefit)) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpenseBenefitDetails </Role>
<ShortName> Income Taxes (Reconciliation of Income Tax Expense (Benefit)) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 61 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 41305 - Disclosure - Income Taxes (Significant Components of Deferred Tax Assets and Liabilities) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails </Role>
<ShortName> Income Taxes (Significant Components of Deferred Tax Assets and Liabilities) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 62 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 41306 - Disclosure - Income Taxes (Schedule of Deferred Tax Amounts Classified in Balance Sheets) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAmountsClassifiedInBalanceSheetsDetails </Role>
<ShortName> Income Taxes (Schedule of Deferred Tax Amounts Classified in Balance Sheets) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 63 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 41401 - Disclosure - Paycheck Protection Program (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosurePaycheckProtectionProgramNarrativeDetails </Role>
<ShortName> Paycheck Protection Program (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosurePaycheckProtectionProgram </ParentRole>
<Position> 64 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 41501 - Disclosure - Net (Loss) Income Per Share (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureNetLossIncomePerShareNarrativeDetails </Role>
<ShortName> Net (Loss) Income Per Share (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureNetLossIncomePerShareTables </ParentRole>
<Position> 65 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R66.htm </HtmlFileName>
<LongName> 41502 - Disclosure - Net (Loss) Income Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureNetLossIncomePerShareScheduleOfEarningsPerShareBasicAndDilutedDetails </Role>
<ShortName> Net (Loss) Income Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureNetLossIncomePerShareTables </ParentRole>
<Position> 66 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R67.htm </HtmlFileName>
<LongName> 41601 - Disclosure - Industry Segments (Narrative) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIndustrySegmentsNarrativeDetails </Role>
<ShortName> Industry Segments (Narrative) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIndustrySegmentsTables </ParentRole>
<Position> 67 </Position>
</Report>
<Report instance="veru-20210630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R68.htm </HtmlFileName>
<LongName> 41602 - Disclosure - Industry Segments (Schedule of Segment Reporting Information) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://verupharma.com/role/DisclosureIndustrySegmentsScheduleOfSegmentReportingInformationDetails </Role>
<ShortName> Industry Segments (Schedule of Segment Reporting Information) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://verupharma.com/role/DisclosureIndustrySegmentsTables </ParentRole>
<Position> 68 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-Q" original="veru-20210630x10q.htm"> veru-20210630x10q.htm </File>
<File> veru-20210630.xsd </File>
<File> veru-20210630_cal.xml </File>
<File> veru-20210630_def.xml </File>
<File> veru-20210630_lab.xml </File>
<File> veru-20210630_pre.xml </File>
<File> veru-20210630xex31_1.htm </File>
<File> veru-20210630xex31_2.htm </File>
<File> veru-20210630xex32_1.htm </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/us-gaap/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/country/2020-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

10 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/10/20  Veru Inc.                         10-K        9/30/20  100:9.9M
 3/29/19  Veru Inc.                         8-K:5,9     3/26/19    3:161K                                   Donnelley … Solutions/FA
 5/04/18  Veru Inc.                         8-K:5,9     5/02/18    2:168K                                   Donnelley … Solutions/FA
 8/01/17  Veru Inc.                         8-K:3,5,9   7/28/17    3:190K                                   Donnelley … Solutions/FA
11/02/16  Veru Inc.                         8-K:1,2,3,510/31/16    7:824K                                   Donnelley … Solutions/FA
 5/17/04  Veru Inc.                         10QSB       3/31/04    5:289K                                   Reinhart Boerner … SC/FA
 5/15/03  Veru Inc.                         10QSB       3/31/03    2:79K                                    Reinhart Boerner … SC/FA
 9/06/02  Veru Inc.                         SB-2                   4:270K                                   Reinhart Boerner … SC/FA
 9/21/00  Veru Inc.                         SB-2                   5:302K                                   Reinhart Boerner … SC/FA
10/19/99  Veru Inc.                         SB-2                   5:381K                                   Bowne - Bde
↑Top
Filing Submission 0000863894-21-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., May 12, 1:36:07.2am ET